IL-12 Treatment Attenuates T Helper Cell Type 2 and B Cell Responses but Does Not Improve Vaccine-Enhanced Lung Illness

Journal of Immunology

Volumn 159, Issue 1, 1997, Pages 328-334

  Hussell, Tracy ^b   Khan, Usman ^b   Openshaw, Peter ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; RECOMBINANT VACCINE; VIRUS VACCINE;

ANIMAL; ARTICLE; B LYMPHOCYTE; BAGG ALBINO MOUSE; CELLULAR IMMUNITY; DRUG EFFECT; FEMALE; HUMAN; IMMUNOLOGY; MOUSE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TH2 CELL; VIRUS INFECTION;

ANIMALS; B-LYMPHOCYTES; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; TH2 CELLS; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0031181334     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. + T-cell subsets: regulation of differentiation and function. Res. Immunol. 142:7.
2. + T helper type 2 cells. J. Exp. Med. 181:5.
3. + T cells secreting Th1 or Th2 cytokines. Immunity 2:271.
4. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138.
5. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227.
6. + T helper lype 2 T lymphocytes do not promote recovery from experimental virus infection. J. Exp. Med. 180:1273.
7. + T-cell subsets in the regulation of parasite immunity and disease. Immunol. Rev. 112:161.
8. Alwan, W. H., W. Kozlowska, and P. J. M. Openshaw 1994. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179: 81.
9. Openshaw, P. J. M. 1995. Immunopathological mechanisms in respiratory syncytial virus disease. Semin. Immunopathol. 17:187.
10. Heilman, C. A. 1990. Respiratory syncytial and parainfluenza viruses. J. Infect. Dis. 161:402.
11. Sigurs, N., R. Bjarnason, F. Sigurbergsson, B. Kjellman, and B. Bjorksten. 1995. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 95:500.
12. McIntosh, K., and J. M. Fishaut. 1980. Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus. Prog. Med. Virol. 26:94.
13. Cannon, M. J., P. J. M. Openshaw, and B. A. Askonas. 1988. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168:1163.
14. Openshaw, P. J. M., S. L. Clarke, and F. M. Record. 1992. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int. Immunol. 4:493.
15. Alwan, W. H., F. M. Record, and P. J. M. Openshaw. 1993. Phenotypic and functional characterization of T cell lines specific to individual respiratory syncytial virus proteins. J. Immunol. 150:5211.
16. Trinchieri, G. 1995. Interleukin-12: a proinfiammatory cytokine with immuno-regulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
17. + T cells. J. Immunol. 154:5071.
18. Bangham, C. R. M., M. J. Cannon, D. T. Karzon, and B. A. Askonas. 1985. Cytotoxic T-cell response to respiratory syncytial virus in mice. J. Virol. 56:55.
19. Hussell, T., L. C. Spender, A. Georgiou, A. O'Garra, and P. J. M. Openshaw. 1996. Th1 and Th2 cytokine induction in pulmonary T-cells during infection with respiratory syncytial virus. J. Gen. Virol. 77:2447.
20. Openshaw, P. J. M., E. E. Murphy, N. A. Hosken, V. Manio, K. Davis, and A. O'Garra. 1995. Heterogeneity of intracellular cytokine synthesis at the single cell level in polarised T helper 1 and T helper 2 populations. J. Exp. Med. 182: 1357.
21. Orange, J. S., S. F. Wolf, and C. A. Biron. 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152:1253.
22. Fong, Y., K. J. Tracey, L. L. Moldawer, D. G. Hesse, K. B. Manogue, J. S. Kenney, A. T. Lee, G. C. Kuo, A. C. Allison, S. F. Lowry, and A. Cerami. 1989. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J. Exp. Med. 170:1627.
23. Gruber, J., R. Sgonc, Y. H. Hu, H. Beug, and G. Wick. 1994. Thymocyte apoptosis induced by elevated endogenous corticosterone levels. Eur. J. Immunol. 24:1115.
24. + natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12. Eur. J. Immunol. 23:1831.
25. Williams, J. G., G. J. Jurkovich, G. B. Hahnel, and R. V. Maier, 1992. Macrophage priming by Interferon gamma: a selective process with potentially harmful effects. J. Leukocyte Biol. 52:579.
26. Orange, J. S., T. P. Salazar Mather, S. M. Opal, R. L. Spencer, A. H. Miller, B. S. McEwen, and C. A. Biron. 1995. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181:901.
27. Wang, Z. E., S. Zheng, D. B. Corry, D. K. Dalton, R. A. Seder, S. L. Reiner, and R. M. Locksley, 1994, Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc. Natl. Acad Sci. USA 91:12932.
28. Nabors, G. S., L. C. Afonso, J. P. Farrel, and P. Scott. 1995. Switch from a type 2 to a type 1 T helper cell response und cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam. Proc. Natl. Acad. Sci. USA 92:3142.
29. Sypek, J. P., C. L. Chung, S. E. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797.
30. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
31. Murray, H. W., and J. Hariprashad. 1995. Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181:387.
32. Engwerda, C. R., B. S. Handwerger, and B. S. Fox. 1994. Aged T cells are hyporesponsive to costimulation mediated by CD28. J. Immunol. 152:3740.
33. Tang, Y. W., and B. S. Graham. 1995. Interleukin-12 treatment during immunization elicits a T helper cell type 1 -like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity. J. Infect. Dis. 172:734.
34. Graham, B. S., L. A. Bunton, J. Rowland, P. F. Wright, and D. T. Karzon. 1991. Respiratory syncytial virus infection in anti-μ-treated mice. J. Virol. 65:4936.
35. Johnson, E. D., A. A. Monjan, and H. C. Morse. 1978. Lack of B-cell participation in acute lymphocyte choriomeningitis disease of the central nervous system. Cell. Immunol. 36:143.
36. H2 subsets; doubt no more. Immunol. Today 12:256.
37. Coffman, R. L., B. W. P. Seymour, S. Hudak, J. Jackson, and D. Rennick. 1989. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245:308.
38. Sanderson, C. J. 1992. Interleukin-5, eosinophils, and disease. Blood 79:3101.
39. Waris, M. E., C. Tsou, D. D. Erdman, S. R. Zaki, and L. J. Anderson. 1996. Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J. Virol 70:2852.
40. Heymann, P. W., G. P. Rakes, A. D. Hogan, J. M. Ingram, G. E. Hoover, and T. A. E. Platts-Mills. 1995. Assessment of eosinophils, viruses and IgE antibody in wheezing infants and children. Int. Arch. Allergy Immunol. 107:380.
41. Plaut, M., J. H. Pierce, C. J. Watson, J. Hanley Hyde, R. P. Nordan, and W. E. Paul. 1989. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 339:64.
42. Wodnar Filipowicz, A., C. H. Heusser, and C. Moroni. 1989. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 339:150.
43. Urban, J. F. J., K. B. Madden, A. Svetic, A. Cheever, P. P. Trotta, W. C. Gause, I. M. Katona, and F. D. Finkelman. 1992. The importance of Th2 cytokines in protective immunity to nematodes. Immunol. Rev. 127:205.
44. Svetic, A., K. B. Madden, X. D. Zhou, P. Lu, I. M. Katona, F. D. Finkelman, J. F. J. Urban, and W. C. Gause. 1993. A primary intestinal helminthic infection rapidly induces a gut-associated elevation of Th2-associated cytokines and IL-3. J. Immunol. 150:3434.
45. Lu, P., J. F. Urban, X. Di Zhou, S. J. Chen, K. Madden, M. Moorman, H. Nguyen, S. C. Morris, F. D. Finkelman, and W. C. Gause. 1996. CD40-mediated stimulation contributes to lymphocyte proliferation, antibody production, eosinophilia, and mastocytosis during: an in vivo type 2 response, but is not required for T cell IL-4 production. J. Immunol. 156:3327.
46. Lu, P., X. Zhou, S. J. Chen, M. Moorman, S. C. Morris, F. D. Finkelman, P. Linsley, J. F. Urban, and W. C. Gause. 1994. CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite, J. Exp. Med. 180:693.